FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Cardiac Biotech Solutions Inc. Stock AnalysisComprehensive stock analysis for Cardiac Biotech Solutions Inc. (CBSC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCBSC
CBSC
Cardiac Biotech Solutions Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CBSC
Home🔹Stocks🔹Cardiac Biotech Solutions Inc.

Cardiac Biotech Solutions Inc.

CBSC•OTC

Cardiac Biotech Solutions Inc.

CBSC•OTC
Market cap
$6.64M
Sentiment

Your view on CBSC

Mkt Cap
$6.64M
Sentiment
Your view
CBSC
Cardiac Biotech Solutions Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
CBSC
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cardiac Biotech Solutions Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Charles K. Martin
Headquarters
340 State Place, Las Vegas, CA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Charles K. Martin
Headquarters
340 State Place, Las Vegas, CA, US
Description

Cardiac Biotech Solutions Inc., through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians. Cardiac Biotech Solutions' wholly owned U.S. subsidiary, My-Cardia (USA), Inc., develops ECG recording device worn by patients in an ambulatory setting for up to 30 days.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News